Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.
Smith CH, Yiu ZZN, Bale T, Burden AD, Coates LC, Edwards W, MacMahon E, Mahil SK, McGuire A, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Uthman OA, Woolf RT, Manounah L, Ezejimofor MC, Exton LS, Mohd Mustapa MF; British Association of Dermatologists’ Clinical Standards Unit. Smith CH, et al. Among authors: burden ad. Br J Dermatol. 2020 Oct;183(4):628-637. doi: 10.1111/bjd.19039. Epub 2020 Jul 21. Br J Dermatol. 2020. PMID: 32189327 No abstract available.
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.
Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; British Association of Dermatologists. Smith CH, et al. Among authors: burden ad. Br J Dermatol. 2005 Sep;153(3):486-97. doi: 10.1111/j.1365-2133.2005.06893.x. Br J Dermatol. 2005. PMID: 16120132 No abstract available.
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; (Chair of Guideline Group). Smith CH, et al. Among authors: burden ad. Br J Dermatol. 2009 Nov;161(5):987-1019. doi: 10.1111/j.1365-2133.2009.09505.x. Br J Dermatol. 2009. PMID: 19857207 No abstract available.
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.
Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, Knight J, Spain SL, Nestle FO, Burden AD, Capon F, Trembath RC, Barker JN. Onoufriadis A, et al. Among authors: burden ad. Am J Hum Genet. 2011 Sep 9;89(3):432-7. doi: 10.1016/j.ajhg.2011.07.022. Epub 2011 Aug 11. Am J Hum Genet. 2011. PMID: 21839423 Free PMC article.
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.
Laws PM, Downs AM, Parslew R, Dever B, Smith CH, Barker JN, Moriarty B, Murphy R, Kirby B, Burden AD, McBride S, Anstey AV, O'Shea S, Ralph N, Buckley C, Griffiths CE, Warren RB. Laws PM, et al. Among authors: burden ad. Br J Dermatol. 2012 Jan;166(1):189-95. doi: 10.1111/j.1365-2133.2011.10638.x. Br J Dermatol. 2012. PMID: 21929536
161 results